ERBB2 and prostate adenocarcinoma: MESO, mesothelioma; BRCA (Her2), Her2 positive breast invasive carcinoma; DLBC, diffuse large B-cell lymphoma; ESCA, esophageal carcinoma; HNSC-HPVpos, HPV positive head and neck cancer; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LGG, low grade glioma; LIHC, liver hepatocellular carcinoma; LUSC, lung squamous cell carcinoma; PRAD, prostate adenocarcinoma; SARC, sarcoma; SKCM, skin cutaneous melanoma; THCA, thyroid carcinoma; Cor, R value of Spearman’s correlation.